Drug intelligence / Profile preview

hydrochlorothiazide + reserpine

Development stage
Discontinued
Lead developer
Novartis
Modality
Small Molecules
Administration
Oral
01

Overview

**Hydrochlorothiazide + reserpine** is an oral combination drug used primarily to treat **hypertension (high blood pressure)**. Hydrochlorothiazide is a thiazide diuretic ("water pill") that works by increasing urine production, reducing fluid volume, and thus lowering blood pressure. Reserpine, a rauwolfia alkaloid, acts centrally by irreversibly blocking VMAT2 (vesicular monoamine transporter 2), depleting monoamine neurotransmitters such as norepinephrine, dopamine, and serotonin from nerve endings, resulting in reduced sympathetic nervous system activity and lower blood pressure. This combination is effective at reducing both systolic and diastolic blood pressure, and has shown comparable efficacy to other antihypertensive regimens in clinical studies[3][6]. It is no longer marketed in the United States but is still in use in some countries[2].

Brand names
HydropresHydro-ReserpHydroserpHydroserpineMallopress
Other names
reserpine + hydrochlorothiazide
02

Targets

SLC12A3 (Thiazide-sensitive sodium-chloride cotransporter)VMAT2 (Vesicular monoamine transporter 2)

Beyond the preview

Go deeper on hydrochlorothiazide + reserpine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydrochlorothiazide + reserpine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call